07 Oct 2025 | 5 Mins Read
Zydus Lifesciences gets 2 key approvals from Health Canada and USFDA
Flipitmoney
Zydus Lifesciences received regulatory approvals from Health Canada and the USFDA. Health Canada approved generic Liothyronine tablets for hypothyroidism treatment, while the USFDA approved Deflazacort oral suspension for Duchenne Muscular Dystrophy. The approvals will be manufactured at Zydus's Ahmedabad SEZ plant and Doppel, Italy facility, respectively, adding to its 424 cumulative approvals.